Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지

Co-expression of Survivin and Bcl-2 in Primary Brain Tumors : Their Potential Effect on Anti-apoptosis

  • Ryu, Je-Il (Departments of Neurosurgery, School of Medicine, Hanyang University) ;
  • Kim, Choong-Hyun (Departments of Neurosurgery, School of Medicine, Hanyang University) ;
  • Cheong, Jin-Hwan (Departments of Neurosurgery, School of Medicine, Hanyang University) ;
  • Bak, Koang-Hum (Departments of Neurosurgery, School of Medicine, Hanyang University) ;
  • Kim, Jae-Min (Departments of Neurosurgery, School of Medicine, Hanyang University) ;
  • Oh, Suck-Jun (Departments of Neurosurgery, School of Medicine, Hanyang University)
  • Published : 2006.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Survivin is an inhibitor of apoptosis protein[IAP], which inhibits apoptosis through a pathway distinct from the Bcl-2 family members. Overexpression of survivin and Bcl-2 have been commonly reported in human neoplasms. The authors investigate whether there is a synergistic effect on the anti-apoptosis rate of primary brain tumors "in situ" based on the co-expression of survivin and Bcl-2. Methods : One hundred and two brain tumor patients who had been resected were included in this study. Survivin tin and Bcl-2 were detected by Western blotting analysis, while apoptosis was examined by DNA fragmentation analysis. An anti-apoptotic rate was assessed in these brain tumor samples based on the expression of survivin and Bcl-2 or co-expression of both. Results : Survivin and Bcl-2 were expressed in 57[55.9%] and 53[52.0%] of 102 brain tumor samples studied respectively, and co-expressed in 31[30.4%]. The percentage of astrocytic and meningeal tumors expressing survivin was significantly correlated with histological grades; however, Bcl-2 was not correlated [p=0.106]. The anti-apoptotic rate in primary brain tumors with survivin, Bcl-2, and both was detected in 49[86.0%] of 57 samples, 42[79.9%] of 53 samples, and 27[87.1%] of 31 samples, respectively. Their difference in the frequency of anti-apoptosis was not significant. Conclusion : Survivin or Bcl-2 is involved in the anti-apoptosis. However, it suggests that co-expression of survivin and Bcl-2, together, have no synergistic effect on the anti-apoptotic properties of the primary brain tumors.

Keywords

References

  1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC : Antiapoptosis gene, survivin, and prognosis of neuroblastomas. Lancet 351 : 882- 883, 1998 https://doi.org/10.1016/S0140-6736(05)70294-4
  2. Ambrosini G, Adida C, Altieri DC : A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med 8 : 917-921, 1997
  3. Ambrosini G, Adida C, Sirugo G, Altieri DC : Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273 : 1177-1182, 1998
  4. Ashhab Y, Alian A, Polliack A, Panet A, Ben YD : Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 495 : 56-60, 2001 https://doi.org/10.1016/S0014-5793(01)02366-3
  5. Chakravarti A, Noll E, Black PM, Finkelstein DM, Dyson NJ, Loeffler JS : Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20: 1063-1068, 2002 https://doi.org/10.1200/JCO.20.4.1063
  6. Cherbonnel-Lasserre C, Dosanjh MK : Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage. Biochimie 79 : 613-617, 1997 https://doi.org/10.1016/S0300-9084(97)82011-1
  7. Formby B, Wiley TS : Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone : inhibition of cell growth and induction of apoptosis. Mol Cell Biochem 202 : 53- 61, 1999 https://doi.org/10.1023/A:1007081021483
  8. Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, et al : Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J Clin Oncol 21 : 306-312, 2003 https://doi.org/10.1200/JCO.2003.08.066
  9. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, et al : Expression of survivin in astrocytic tumors correlations with malignant grade and prognosis. Cancer 97 : 1077-1083, 2003 https://doi.org/10.1002/cncr.11122
  10. Kawasaki H, Altieri DC, Lu CD, Toxoda M, Temjo T, Tanigawa N : Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58 : 5071-5074, 1998
  11. Kayaselcuk F, Zorludemir S, Bal N, Erdogan B, Erdogan S, Erman T : The expression of survivin and Ki-67 in meningiomas : correlation with grade and clinical outcome. J. Neurooncol 67 : 209-214, 2004 https://doi.org/10.1023/B:NEON.0000021823.05163.2c
  12. Kim CH, Cheong JH, Bak KH, Kim JM, Ko Y, Oh SJ : p53 and Bcl-2 expression and apoptosis in human brain tumors. J Korean Neurosurg Soc 31: 357-363, 2002
  13. Kleinschmidt-DeMasters BK, Heinz D, McCarthy PJ, Bobak JB, Lillehei K, Shroyer ALW, et al : Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels. Arch Pathol Lab Med 127 : 826-833, 2003
  14. LaCasse E, Baird S, Korneluk RG, MacKenzie AE : The inhibitior of apoptosis( IAP) and their emerging role in cancer. Oncogene 17 : 3247-3259, 1998 https://doi.org/10.1038/sj.onc.1202569
  15. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al : Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584, 1998 https://doi.org/10.1038/26931
  16. Lu CD, Altieri DC, Tanigawa N : Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58 : 1808-1812, 1998
  17. Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC, et al : Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 158 : 1757-1765, 2001 https://doi.org/10.1016/S0002-9440(10)64131-4
  18. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, et al : Regulation of apoptosis at cell division by $ p34^{cdc}2$ phosphorylation of survivin. Proc Natl Acad Sci 97 : 13103-13107, 2000
  19. O'Connor DS, Schechner JS, Adida C, Mersi M, Rothermel AL, Nath AK, et al : Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156 : 393-398, 2000 https://doi.org/10.1016/S0002-9440(10)64742-6
  20. Rodel F, Hoffman J, Grabenbauer GG, Papadopoulos T, Weiss C, Gunther K, et al : High survivin expression is associated with reduced apoptosis. Strahlenther Onkol 178 : 426-435, 2002 https://doi.org/10.1007/s00066-002-1003-y
  21. Sasaki T, Lopes MBS, Hankins GR, Helm GA : Expression of survivin, an inhibitor of apoptosis protein in tumor of the nervous system. Acta Neuropathol 104 : 105-109, 2002 https://doi.org/10.1007/s00401-002-0532-x
  22. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al : IAP family protein survivin inhibit caspase activity and apoptosis induced by Fas(CD95), Bax, caspase, and anticancer drugs. Cancer Res 58 : 5315-5320, 1998
  23. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N : Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6 : 127-134, 2000
  24. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG, et al : Marked induction of the IAP family anti-apoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781-788, 1999 https://doi.org/10.1006/bbrc.1999.1589
  25. Tsujimoto Y, Cossman J, Jaffe E, Croce CM : Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 : 1440-1443, 1985 https://doi.org/10.1126/science.3874430
  26. Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, et al : Prognostic significance of the immunohistochemical index of survivin in glioma : a comparative study with the MIB-1 index. J Neurooncol 72 : 231-238, 2005 https://doi.org/10.1007/s11060-004-2353-3
  27. Vaux DL, Haecker G, Strasser A : An evolutionary perspective on apoptosis. Cell 76 : 777-779, 1994 https://doi.org/10.1016/0092-8674(94)90350-6
  28. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M : Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 75 : 2288-2297, 2000 https://doi.org/10.1046/j.1471-4159.2000.0752288.x
  29. Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, et al : Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 99 : 738-745, 2003 https://doi.org/10.3171/jns.2003.99.4.0738
  30. Zhang SL, Zhao CQ, Lin B, Li Y, Gao H : Expression of survivin gene and its relation with the expression of Bcl-2 and Bax protein in epithelial ovarian cancer. Zhonghua Fu Chan Ke ZaZahi 38 : 203-206, 2003